Workflow
爱迪特9月17日获融资买入580.68万元，融资余额1.18亿元
Xin Lang Cai Jing·2025-09-18 01:39

Core Insights - Aidi Te's stock price decreased by 0.75% on September 17, with a trading volume of 34.80 million yuan. The financing data indicates a net financing outflow of 1.80 million yuan for the day [1] Financing Overview - On September 17, Aidi Te had a financing buy-in amount of 5.81 million yuan, while the financing repayment was 7.61 million yuan, resulting in a net financing buy-in of -1.80 million yuan. The total financing and securities balance reached 11.80 million yuan, accounting for 3.55% of the circulating market value, which is above the 80th percentile of the past year [1] - The company had no shares sold short or repaid on September 17, with a short selling balance of 4615.00 yuan, which is also above the 90th percentile of the past year [1] Company Profile - Aidi Te (Qinhuangdao) Technology Co., Ltd. was established on March 15, 2007, and is located in Qinhuangdao, Hebei Province. The company specializes in the research, production, and sales of zirconia ceramic blocks and other dental restoration materials with international competitiveness. The revenue composition includes 73.74% from dental restoration materials, 19.80% from dental digital equipment, and 6.46% from other products and services [1] Financial Performance - As of June 30, Aidi Te reported a total of 9,412 shareholders, an increase of 17.12% from the previous period. The average circulating shares per person rose to 7,651, an increase of 223.12% [2] - For the first half of 2025, Aidi Te achieved a revenue of 486 million yuan, representing a year-on-year growth of 17.22%. The net profit attributable to the parent company was 92.04 million yuan, reflecting a year-on-year increase of 19.86% [2] Dividend Information - Aidi Te has distributed a total of 49.48 million yuan in dividends since its A-share listing [3] Institutional Holdings - As of June 30, 2025, several funds exited the top ten circulating shareholders list, including Huatai-PineBridge Value Selection Mixed Fund, Galaxy Medical Mixed A, and others [3]